NLS PHARMACEUTICS LTD (NLSP)

CH0523961370 - Common Stock

1.95  -0.43 (-18.07%)

After market: 1.9 -0.05 (-2.56%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
N/AN/A
EBITDA
YoY % growth
N/AN/AN/AN/A-11.85M-15.47M
-30.55%
-11.796M
23.75%
N/AN/A
EBIT
YoY % growth
-5.77M-3.45M
40.21%
-4.2M
-21.74%
-2.3M
45.24%
-11.86M
-415.65%
-15.48M
-30.52%
-11.807M
23.73%
N/A
81.91%
N/A
-1,175.26%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/AN/AN/A
-5.88%
N/A
-1.24%
N/A
30.49%
N/A
89.47%
N/A
71.88%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% -3900%
RevenueN/A N/A N/A N/A